OpenBilldrug price receipt

NADAC week of 2026-10-14

MESALAMINE DR 1.2 GM TABLET

For 30 tablets

Pharmacies pay

$23.43 filed

30 × $0.7809 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$60.30 filed

30 × $2.00989 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

2.6× estimated

Medicare paid 2.6× what pharmacies pay.

Part D averages every strength and form sold under “Mesalamine Dr” / “Mesalamine” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$31.94 estimated

$23.43 + $3.51 (15%) + $5.00 fee per fill = $31.94

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

MESALAMINE DR 1.2 GM TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as mesalamine.

FDA gives its dosage form as tablet, delayed release and its route as oral.

FDA lists 9 labelers (the companies named on the label) for its NDCs, among them Lannett Company Inc., Actavis Pharma, Inc. and Major Pharmaceuticals.

FDA’s Established Pharmacologic Class for it is Aminosalicylate.

The NADAC file of 2026-10-14 prices it under 11 NDCs (National Drug Codes); the FDA directory lists 10 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $23.43 for 30 tablets (30 × $0.7809 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 9 labelers

LabelerNDCsPharmacies pay per unit
Chartwell RX, LLC2$0.7809 per EA filed
Actavis Pharma, Inc.1$0.7809 per EA filed
American Health Packaging1$0.7809 per EA filed
Camber Pharmaceuticals, Inc.1$0.7809 per EA filed
Lannett Company Inc.1$0.7809 per EA filed
Major Pharmaceuticals1$0.7809 per EA filed
NorthStar RxLLC1$0.7809 per EA filed
Sun Pharmaceutical Industries, Inc.1$0.7809 per EA filed
Zydus Pharmaceuticals USA Inc.1$0.7809 per EA filed
Not listed as a package in the FDA directory1$0.7809 per EA filed
All 11 NDCs, with labeler and price
  • 00527-3012-48 · Lannett Company Inc. · $0.7809 per EA · eff. 2026-09-23 filed
  • 00591-2245-22 · Actavis Pharma, Inc. · $0.7809 per EA · eff. 2026-09-23 filed
  • 00904-6832-04 · Major Pharmaceuticals · $0.7809 per EA · eff. 2026-09-23 filed
  • 31722-0043-12 · Camber Pharmaceuticals, Inc. · $0.7809 per EA · eff. 2026-09-23 filed
  • 60687-0397-25 · American Health Packaging · $0.7809 per EA · eff. 2026-09-23 filed
  • 60687-0397-95 · not listed as a package in the FDA directory · $0.7809 per EA · eff. 2026-09-23 filed
  • 62135-0714-12 · Chartwell RX, LLC · $0.7809 per EA · eff. 2026-09-23 filed
  • 62135-0714-60 · Chartwell RX, LLC · $0.7809 per EA · eff. 2026-09-23 filed
  • 63304-0175-13 · Sun Pharmaceutical Industries, Inc. · $0.7809 per EA · eff. 2026-09-23 filed
  • 68382-0711-19 · Zydus Pharmaceuticals USA Inc. · $0.7809 per EA · eff. 2026-09-23 filed
  • 72603-0304-01 · NorthStar RxLLC · $0.7809 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

10 other products in the NADAC file share the FDA nonproprietary name mesalamine with MESALAMINE DR 1.2 GM TABLET.

ProductPharmacies pay per unitMedicare per unit
CANASA 1,000 MG SUPPOSITORY
brand · suppository
$37.10967 per EA filed
eff. 2026-09-23
$36.05608 per EA filed
Part D 2024 average
LIALDA DR 1.2 GM TABLET
brand · tablet, delayed release
$8.94652 per EA filed
eff. 2026-09-23
We don’t know yet
MESALAMINE 1,000 MG SUPP
generic · suppository
$1.28382 per EA filed
eff. 2026-09-23
We don’t know yet
MESALAMINE 4 GM/60 ML ENEMA
generic · suspension / enema
$0.09843 to $0.17585 per ML filed
eff. 2026-09-23
We don’t know yet
MESALAMINE 4 GM/60 ML KIT
generic · kit
$134.90444 per EA filed
eff. 2026-09-23
We don’t know yet
MESALAMINE 800 MG DR TABLET
generic · tablet, delayed release
$4.02045 per EA filed
eff. 2026-09-23
$2.00989 per EA filed
Part D 2024 average
MESALAMINE DR 1.2 GM TABLET this page
generic · tablet, delayed release
$0.7809 per EA filed
eff. 2026-09-23
$2.00989 per EA filed
Part D 2024 average
MESALAMINE DR 400 MG CAPSULE
generic · capsule, delayed release
$2.69898 per EA filed
eff. 2026-09-23
$2.00989 per EA filed
Part D 2024 average
MESALAMINE ER 0.375 GRAM CAP
generic · capsule, extended release
$0.47798 per EA filed
eff. 2026-09-23
$1.37992 per EA filed
Part D 2024 average
PENTASA 250 MG CAPSULE
brand · capsule
$2.90086 per EA filed
eff. 2026-09-23
$5.03307 per EA filed
Part D 2024 average
PENTASA 500 MG CAPSULE
brand · capsule
$5.82619 per EA filed
eff. 2026-09-23
$5.03307 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 11 NDCs’ NADAC prices is $0.7809 per EA filed.

Of the 12 other products in FDA’s Aminosalicylate class priced per EA, 8 have a higher middle NADAC price and 4 a lower one. The one in the middle is MESALAMINE DR 400 MG CAPSULE, at $2.69898 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $60.30 for 30 tablets, at an average of $2.00989 per EA in 2024 (2024-01-01 to 2024-12-31) for “Mesalamine Dr” and “Mesalamine”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 47,962 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for MESALAMINE DR 1.2 GM TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Mesalamine Dr / Mesalamine: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.